Searchable abstracts of presentations at key conferences in endocrinology

ea0070oc2.7 | Bone and Calcium | ECE2020

Surgery alone or surgery in combination with postoperative zoledronic acid for the treatment of osteoporosis in primary hyperparathyroidism: a 2-year double-blind randomized placebo-controlled study

Ryhänen Eeva , Koski Anna-Mari , Eliisa Loyttyniemi , Ulla Kiviniemi , Schalin-Jantti Camilla , Matti Välimäki

Background: Osteoporosis is common in primary hyperparathyroidism (PHPT). It is also an indication for parathyroidectomy in PHPT. Bone mineral density (BMD) measured by dual-energy x-ray absorptiometry (DXA) increases after successful surgery. Alendronate significantly increases BMD in PHPT patients not undergoing surgery. It is not known whether surgery alone or in combination with postoperative zoledronic acid more efficiently improves bone health in PHPT.<p class="abste...